Navigation Links
Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
Date:9/17/2008

ne tablets in delaying the development of definite MS.

In the study, Cladribine tablets are given in two or four treatment cycles in the first year, with each cycle consisting of once daily administration for four to five consecutive days, which means study patients take Cladribine tablets for only 8 to 20 days during that year. In the second year, two treatment cycles are administered to all patient groups.

The primary endpoint of the ORACLE MS trial is time to conversion to MS, according to the McDonald criteria. Other endpoints include time to conversion to clinically definite MS according to the Poser criteria (the main secondary endpoint), assessments of MRI brain scans, and disability progression.

Approximately 200 medical centers globally are expected to participate in this trial.

(1) CLARITY: Cladribine Tablets Treating MS Orally

About Cladribine tablets

Merck Serono's proprietary oral formulation of Cladribine is currently being evaluated in Phase III as a treatment for patients with relapsing forms of multiple sclerosis (MS). Cladribine is a small molecule that may interfere with the behavior and the proliferation of certain white blood cells, particularly lymphocytes, which are thought to be involved in the pathological process of MS.

About Rebif(R)

Rebif(R) (interferon beta-1a) is a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS) and is similar to the interferon beta protein produced by the human body. The efficacy of Rebif(R) in chronic progressive MS has not been established. Interferons are thought to help modulate the body's immune system and reduce inflammation. The exact mechanism is unknown.

Rebif(R), which was approved in Europe in 1998 and in the US in 2002, is registered in more than 80 countries worldwide. Rebif(R) has been proven to delay the progression of disability, reduce the frequency of relapses and reduce MRI lesion activity and area*. Rebif(
'/>"/>

SOURCE Merck Serono International S A
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
4. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
5. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
6. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
7. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
8. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
9. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
10. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
11. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Unichem Pharmaceuticals ( ... one lot of Hydrochlorothiazide tablets 25 mg 1000-count bottle ... as a precautionary measure due to the identification of ... product. The risk associated with mistakenly ... is the increased probability of experiencing Clopidogrel,s side effects ...
(Date:7/30/2015)... Calif. , July 30, 2015  Amgen (NASDAQ: ... , partner and managing director of Warburg Pincus LLC, to ... pleased to welcome Fred Hassan and the deep, ... Amgen Board," said Robert A. Bradway , chairman and ... commitment to innovation will serve Amgen well." Mr. ...
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Regado Biosciences, Inc.,  a privately held company leading ... that Chris Rusconi , PhD, Senior Vice President, Chief ... Vice President , Chief Medical Officer presented an abstract at ... 2010 in Atlanta, Georgia .   The poster, ...
... CINCINNATI , March 15 Kendle ... research organization, today announced its affiliate in China ... obtained ISO 9001:2008 certification from the International Organization for ... in this growing region.  Through KendleWits, Kendle is the ...
Cached Medicine Technology:Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 2Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 4Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 2Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 3Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 4Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 5
(Date:8/2/2015)... Clarkston, Metamora Michigan (PRWEB) , ... ... ... Organ Prolapse (POP) results when the supportive muscles and connective tissues of ... Causes of this weakness and damage include straining, heavy lifting, obesity, constipation, ...
(Date:8/1/2015)... ... August 02, 2015 , ... Back packs can be dangerous? ... however, back packs can wreck havoc on a kid's spine. With school starting again, ... and from school. Make sure you are aware of how to help them prevent ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are enlarged ... women often causing pain and discomfort. Those who spend a lot of time on ... Houston Vein Center is doing what it can to create awareness and provide a ...
(Date:8/1/2015)... ... 01, 2015 , ... Brig and Lita Hart, icons of the network marketing ... Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been a ... have agreed to join their missions of purpose together to change the course of ...
(Date:8/1/2015)... ... , ... Lume Wellness creators Alex, Robert, and Sam have announced update 3.0.1 ... , The app is designed to track various metrics of wellness, including physical ... personal health and use this information for positive behavior modification. Lume Wellness keeps track ...
Breaking Medicine News(10 mins):Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2
... over the last 25 years according to a report published by ... the UK shows a fall in the presence of harmful heavy ... breathe. , Results show a 70% reduction in the average ... average concentration has fallen from 1873 nanograms per cubic metre of ...
... Lifesciences,Corporation (NYSE: EW ), a world leader ... announced today that it has,completed the sale of ... to C.R. Bard, consistent with the terms previously ... a leader in advanced cardiovascular disease,treatments, is the ...
... SOLANA BEACH, Calif., Jan. 14 Fusion Energy,Products, manufacturer ... owned,subsidiary of Bond Laboratories, Inc. (OTC Bulletin Board: BNLB), ... will be joining its,sponsorship commitment to L&M Racing,s Supercross ... of Fusion Energy Products., "BP and am/pm have ...
... for the first time that the brain processes aggression ... drugs - offering insights into our propensity to fight ... football. , The research will be published online the ... Aggression occurs among virtually all vertebrates and is necessary ...
... Assurant Health, a Milwaukee,WI-based national provider of individual ... today it entered into an agreement,that gives its ... and physicians., Under the agreement Assurant Health ... network, which will expand access to medical,facilities in ...
... Routing cue works like a Zip code helps deliver mail, ... researchers have found a way to modify the surface of ... advance that may prove useful in many areas of stem ... at Brigham and Women,s Hospital in Boston modified the surface ...
Cached Medicine News:Health News:Heavy metal slips down UK air quality charts 2Health News:Fusion Energy Teams Up With BP's 'am/pm' Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution 2Health News:Aggression as rewarding as sex, food and drugs 2Health News:Assurant Health Gains Access to Great-West Healthcare's Nationwide Network 2Health News:Assurant Health Gains Access to Great-West Healthcare's Nationwide Network 3Health News:Stem Cells Modified to Home in Where They're Needed 2
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
... Bactiseal EVD Catheter system ... impregnated catheter for external CSF ... bacteria on catheter tube surfaces. ... Advanced Impregnation Process, it reduces ...
Cruchfield Skull Traction Tong, small pattern....
14 cm - 5 1/2, 6.0 mm , for drill handles and hand drills....
Medicine Products: